Trade Mark Journal No.2025/040 3 October 2025

UK00004266791 19 September 2025 (5,16,35,38,44)

Image for mark UK00004266791
International priority date claimed: 10 April 2025 (United States of America) (99131426)
Class 5
Medicated and pharmaceutical preparations for use in connection with humans, namely, antibiotics, antifungals preparations, antivirals, and for treatment of cardiovascular, dermatological, respiratory, central nervous system, gastro-intestinal diseases, autoimmune, metabolic, endocrine, musculo-skeletal, genitourinary, tissue and organ, ocular, ophthalmological, immune system, pain, kidney, urological, and bone diseases and disorders and for the treatment of fibromyalgia, smoking cessation, narcolepsy, excessive daytime sleepiness, alzheimer's disease agitation, migraine, depression, diabetes, hypertension, skin disorders, allergies, asthma, obesity, and hair loss.
Class 16
Printed educational materials in the field of migraines.
Class 35
Promoting public awareness of migraines.
Class 38
Providing an on-line forum for patients and doctors to communicate and discuss depression and treatments for depression.
Class 44
Consulting services in the field of health relating to pharmaceuticals; Providing health information relating to pharmaceuticals; Providing health information relating to pharmaceuticals via a website; Providing medical information relating to pharmaceuticals via a website; Providing news and information in the field of medicine relating to pharmaceuticals; Providing on-line information, news and commentary in the field of health and wellness relating to pharmaceuticals; Providing health information; providing health information via a website; providing medical information via a website; providing medical information in the field of depression and treatments for depression; providing mental health information via a website; providing mental health and wellness information; providing news and information in the field of medicine; providing news and information in the field of mental health about depression and treatments for depression; providing on-line information, news and commentary in the field of health and wellness relating to depression and treatments for depression; Providing healthcare information in the field of migraines; Providing healthcare information in the field of migraines via a website.

Axsome Therapeutics, Inc.

Representative: Keltie LLP